April 24, 2012 — The secondary cancer risk from multi-detector computed tomography (MDCT) scans is low among older adults, according to a study from Stanford University in the April issue of the Journal of the American College of Radiology. A high-speed imaging technique, MDCT is commonly used to diagnose a variety of diseases and conditions. 

Evidence shows that MDCT scanning offers important benefits through more accurate diagnosis and better disease management in a range of medical disorders. However, in the era of MDCT, it has been hypothesized that 1.5 percent to two percent of all cancers may be caused by CT-induced radiation.

“Our study estimates the number of excess cancers due to ionizing radiation in elderly adults. Seniors harbor most diseases that typically rely on CT scanning for diagnosis and management, and therefore receive the highest exposure to CT imaging. What our study found is that the risk of developing a secondary cancer from these CT scans may potentially be lower than previously thought,” said Aabed Meer, author of the study.

A retrospective cohort study was conducted using Medicare claims spanning eight years to assess CT use. The data were analyzed in two four-year cohorts, from 1998 to 2001 and 2002 to 2005. The number and types of CT scans each patient received over the four-year periods were analyzed to determine the percentage of patients exposed to threshold radiation of 50 to 100 mSv (defined as low) and >100 mSv (defined as high). The National Research Council’s Biological Effects of Ionizing Radiation VII models were used to estimate the number of radiation-induced cancers.

“Combining both low-risk and high-risk patient groups (50-100 and >100 mSv), as well as those who received <50 mSv, we estimate that 1,659 cases of cancer (0.03 percent of the study population) will develop in the 1998 to 2001 cohort and 2,185 (0.04 percent of the study population) in the 2002 to 2005 cohort,” said Meer.

CT scans of the head were the most common examinations in both Medicare cohorts, but abdominal imaging delivered the greatest proportion (43 percent in the first cohort and 40 percent in the second cohort) of radiation.

“Although modern CT imaging is a vital part of medical care, its utilization must include a conscious acknowledgment of radiation exposure and an awareness of the pursuant carcinogenic risk. As medical care continues its dependence on advanced technologies such as MDCT, we emphasize the importance of continuing research that encourages the exploration of lower radiation dose technologies,” said Meer.

For more information: www.jacr.org


Related Content

News | Oncology Information Management Systems (OIMS)

May 30, 2024 — RaySearch Laboratories AB announced the release of the latest version of RayCare, the next generation ...

Time May 30, 2024
arrow
News | Radiology Business

May 29, 2024 — Strategic Radiology added a third California member to the nation’s leading coalition of independent ...

Time May 29, 2024
arrow
News | Lung Imaging

May 24, 2024 — Smokers who have small abnormalities on their CT scans that grow over time have a greater likelihood of ...

Time May 24, 2024
arrow
News | Radiology Business

May 22, 2024 — Medtronic has announced new preliminary data from the VERITAS clinical study using its ILLUMISITE ...

Time May 22, 2024
arrow
News | Artificial Intelligence

May 15, 2024 — Heart disease is the leading cause of mortality in the U.S., accounting for one out of every five deaths ...

Time May 15, 2024
arrow
News | Pediatric Imaging

May 15, 2024 — Transfer learning (TL) models trained on heterogeneous public datasets and fine-tuned using institutional ...

Time May 15, 2024
arrow
News | Radiology Business

May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on ...

Time May 14, 2024
arrow
News | Prostate Cancer

May 13, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, unveils ...

Time May 13, 2024
arrow
News | Radiology Imaging

May 13, 2024 — National Basketball Association (NBA), the National Basketball Players Association (NBPA), and the Next ...

Time May 13, 2024
arrow
News | Contrast Media

May 8, 2024 — Swedish biotech company Ascelia Pharma AB has announced that its liver imaging drug candidate, Orviglance ...

Time May 08, 2024
arrow
Subscribe Now